HIV treatment use increases in the US Between 2000 and 2008, the
proportion of HIV-infected patients in the U.S. receiving
effective treatment known as highly active antiretroviral
therapy (HAART) increased, and HIV-infected patients appeared to
be less infectious and have healthier immune systems at death,
according to a study led by researchers at the Johns Hopkins
Bloomberg School of Public Health. The study was nested in the
NA-ACCORD (North American AIDS Cohort Collaboration on Research
and Design), which is the largest cohort of HIV-infected adults
in North America. The findings are published in the September 4
edition of Annals of Internal Medicine. The study included more
than 45,000 HIV-infected participants receiving clinical care
for HIV. The study population was demographically similar to the
U.S. population living with HIV, according to national
surveillance data from the Centers for Disease Control and
Prevention. Over the study period, the researchers found that
the proportion of HIV-infected p